Investors with a lot of money to spend have taken a bullish stance on Cloudflare NET. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

It was reported on June 4, that Constantine Xykis, CEO at Power Solutions Intl PSIX executed a significant insider sell, according to an SEC filing. What Happened: Xykis's recent move involves selling 23,333 shares of Power Solutions Intl. This information is documented in a Form 4 filing with ...

MongoDB reported better-than-expected first-quarter earnings on Wednesday after the market closed. The company posted sales of $549.01 million, beating the consensus estimate of $528.22 million. Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings-Live With Chris Capre on Wednesday, June ...

NBA star Tristan Thompson spoke with Decrypt at Bitcoin 2025, dishing on assets and athletes alike as he navigates the crypto space.

FT. LAUDERDALE, Fla., June 05, 2025 ( GLOBE NEWSWIRE ) -- iQor CXBPO™, an award-winning customer experience business process outsourcing ( BPO ) provider, today announced the launch of infinityAiQ™, a unified intelligence platform that combines human expertise, AI, and analytics to optimize ...

The Cetus DEX exploit on Sui drained $220 million in minutes. The hacker took advantage of an undetected bug in the math library of the protocol to siphon off the funds.

Williams-Sonoma WSM has outperformed the market over the past 10 years by 4.12% on an annualized basis producing an average annual return of 15.09%. Currently, Williams-Sonoma has a market capitalization of $19.76 billion.

Humana supports limiting payments for diagnoses made only during insurer-led home visits. UnitedHealth led in home visit billing gains, averaging $2,735 per visit vs. $1,525 for Humana. Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings-Live With Chris Capre on Wednesday, June 11.

DAZALS trial missed its main goal, but patients on 300 mg dazucorilant had significantly improved survival at 24 weeks. ROSELLA trial met its endpoint, showing a 30% reduced risk of progression in ovarian cancer with relacorilant plus nab-paclitaxel.

IperionX secured a $99M DoD contract to supply U.S.-made titanium for defense applications. Initial orders will deliver high-performance fasteners made at its Virginia facility, supporting local skilled jobs. Get access to the leaderboards pointing to tomorrow's biggest stock movers.